Correlation Between Inovio Pharmaceuticals and Coya Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Inovio Pharmaceuticals and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inovio Pharmaceuticals and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inovio Pharmaceuticals and Coya Therapeutics, Common, you can compare the effects of market volatilities on Inovio Pharmaceuticals and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inovio Pharmaceuticals with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inovio Pharmaceuticals and Coya Therapeutics,.
Diversification Opportunities for Inovio Pharmaceuticals and Coya Therapeutics,
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Inovio and Coya is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Inovio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inovio Pharmaceuticals are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Inovio Pharmaceuticals i.e., Inovio Pharmaceuticals and Coya Therapeutics, go up and down completely randomly.
Pair Corralation between Inovio Pharmaceuticals and Coya Therapeutics,
Considering the 90-day investment horizon Inovio Pharmaceuticals is expected to generate 1.13 times more return on investment than Coya Therapeutics,. However, Inovio Pharmaceuticals is 1.13 times more volatile than Coya Therapeutics, Common. It trades about 0.02 of its potential returns per unit of risk. Coya Therapeutics, Common is currently generating about 0.02 per unit of risk. If you would invest 456.00 in Inovio Pharmaceuticals on September 3, 2024 and sell it today you would lose (21.00) from holding Inovio Pharmaceuticals or give up 4.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inovio Pharmaceuticals vs. Coya Therapeutics, Common
Performance |
| Timeline |
| Inovio Pharmaceuticals |
| Coya Therapeutics, Common |
Inovio Pharmaceuticals and Coya Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inovio Pharmaceuticals and Coya Therapeutics,
The main advantage of trading using opposite Inovio Pharmaceuticals and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inovio Pharmaceuticals position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.| Inovio Pharmaceuticals vs. CytomX Therapeutics | Inovio Pharmaceuticals vs. Assembly Biosciences | Inovio Pharmaceuticals vs. Achilles Therapeutics PLC | Inovio Pharmaceuticals vs. Instil Bio |
| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |